PIH vs PIE: How to Tell Them Apart (and Why It Matters Most on Darker Skin)

TL;DR. A brown / dark mark left after acne or injury is PIH — post-inflammatory hyperpigmentation, caused by excess melanin. A red / pink / purple mark is PIE — post-inflammatory erythema, caused by damaged blood vessels. They look similar. They are not the same. The treatments diverge. PIH is far more common on Fitzpatrick IV–VI skin and is the single most-misread finding in consumer skincare AI.

You broke out a few weeks ago. The pimple is gone but something is still there — a flat mark, slightly darker (or slightly redder) than the skin around it. You ask the internet what to do. Half the answers say "use vitamin C." Half say "use azelaic acid." Both groups are confidently wrong about half the time, because they're answering a different question than the one you're asking.

The question is: which kind of post-acne mark do I have? And the answer matters a lot more on darker skin than on lighter skin, because the wrong protocol on the wrong type can mean six months of wasted effort.

What is PIH?

Post-inflammatory hyperpigmentation is the brown, dark-brown, grey, or even bluish-black mark left behind after the skin has been inflamed — by acne, eczema, insect bites, friction, irritation, or a too-harsh chemical peel. The mechanism is straightforward: inflammation triggers melanocytes (the cells that produce melanin) to over-produce pigment in the affected area. When the inflammation resolves, the excess melanin remains, sitting in the epidermis or, in deeper cases, the dermis.

PIH is much more common on Fitzpatrick phototypes IV, V, and VI — and within those, the Monk Skin Tone scale 6 through 10 — for a simple reason: more melanocyte activity at baseline means a stronger pigmentary response to any inflammatory trigger. A tiny pimple on Fitzpatrick II skin might leave a faint pink mark for two weeks. The same tiny pimple on Fitzpatrick V skin can leave a brown mark that lasts six months without intervention.

That asymmetry is not a moral failing of darker skin. It is how melanin biology works. And it is exactly the asymmetry most skincare advice fails to take seriously.

What is PIE?

Post-inflammatory erythema is the red, pink, or purple-pink mark left behind after the same kinds of inflammation — but here the underlying cause is not melanin. It's vascular. The inflammation damages or dilates capillaries in the dermis, leaving a visible vascular flush that persists for weeks or months after the acne lesion itself has healed.

PIE is much more common on Fitzpatrick I, II, and III skin, where there is less melanin to mask the underlying vascular response. On lighter skin, the redness reads clearly as redness. On darker skin, the same vascular response can read as warmth, swelling, a deepened darkness, or a violaceous (purple-tinted) cast — which is one of the reasons rosacea is so consistently under-diagnosed on melanin-rich skin.

The five ways to tell which one you have

1. The blanch test. The most reliable self-check: press a clean glass slide (or your phone screen in a pinch) firmly against the mark for about five seconds. PIE blanches — it turns lighter under pressure because the blood is being temporarily pushed out of the capillaries. PIH does not blanch — the mark stays the same colour because it's pigment, not blood. This single test resolves most PIH/PIE confusion in five seconds.
2. Colour, honestly assessed. Brown, tan, grey, dark-brown, or bluish-black? Likely PIH. Pink, red, crimson, or purple-pink? Likely PIE. The trick on darker skin is that PIE can look "darker" rather than "redder" to an untrained eye — see the blanch test.
3. Your Fitzpatrick type. Not deterministic but informative: Fitzpatrick I–III defaults to PIE, IV–VI defaults to PIH. If you have Fitzpatrick V skin and what you're seeing is unambiguously red and blanches, you have PIE — your skin is allowed to surprise you. The default is just a probability, not a rule.
4. Time course. PIE typically resolves on its own within 3–12 months without intervention (faster on lighter skin, slower if there's recurring inflammation in the same area). PIH on darker skin can persist for 6–24 months without treatment, sometimes longer if you're re-traumatising the area (picking, harsh exfoliation, unprotected sun exposure).
5. Sun exposure response. PIH gets darker with sun exposure, because UV stimulates more melanin in already-active melanocytes. PIE doesn't change much with sun. If your marks visibly darken on a sunny day, that's another PIH signal.

Why most skincare AI gets this wrong

Open most consumer skincare apps, scan a face with mixed PIH and PIE, and you'll get back a single finding: "hyperpigmentation." One bullet. One word. One set of recommended ingredients.

That's not laziness on the part of the app. It's a downstream consequence of how the underlying AI was trained. Dermatology AI training datasets have been audited repeatedly since 2018; the consistent finding is that they over-represent Fitzpatrick I–III skin and under-represent IV–VI. When you train a model on a distribution like that, the model learns to default to patterns it has seen most — which means reading post-acne marks against a baseline of lighter skin where vascular findings are common and the PIH-vs-PIE distinction collapses into a fuzzy "spot."

The fix isn't a different ingredient list. It's a different architectural ordering: any analysis that hopes to read PIH and PIE correctly across the full Fitzpatrick range needs to commit to a tone classification first — Fitzpatrick I–VI plus the Monk Skin Tone scale (1–10) — and interpret findings in that tone context. That's the structural difference between an app that conflates PIH and PIE and one that doesn't. (You can read more about how Lumière implements this in our methodology page.)

Why the treatments diverge

Once you know which one you have, the treatment paths are clearly different:

PIH treatments — target excess melanin

• Daily broad-spectrum SPF 50+, ideally mineral or tinted (iron-oxide-containing). Sun exposure is the single biggest accelerator of PIH on darker skin. Without daily SPF, every other PIH treatment is fighting uphill.
• Niacinamide (5–10%) — interrupts melanin transfer from melanocytes to keratinocytes; well-tolerated on darker skin.
• Tranexamic acid (topical 2–5% or oral under supervision) — increasingly the gold standard for stubborn PIH on Fitzpatrick IV–VI.
• Vitamin C (L-ascorbic acid 10–20%) — both an antioxidant and a melanin-pathway inhibitor. Some darker-skin users find LAA irritating; a magnesium ascorbyl phosphate form is gentler.
• Azelaic acid (10–20%) — works on both pigmentation and acne, generally well-tolerated, useful when you have ongoing breakouts.
• Retinoids (adapalene, tretinoin) — speed up cellular turnover. Introduce slowly on Fitzpatrick V–VI because retinoid irritation can cause new PIH (the irony is real).
• Hydroquinone (2–4%, prescription-strength in many countries) — the most aggressive PIH treatment, with real side-effect risk (ochronosis on darker skin if misused). For severe cases, under dermatologist supervision only.

PIE treatments — target damaged vasculature

• Niacinamide (yes, again — it works on both pathways).
• Centella asiatica (cica) — calms persistent vascular inflammation.
• Azelaic acid — also helps PIE, especially in skin prone to rosacea-style flushing.
• Vascular lasers (PDL, KTP) — the most effective PIE treatment, performed by a dermatologist. On Fitzpatrick I–III, low-risk; on IV–VI, possible but requires an experienced operator using settings calibrated for darker skin.
• Time, plus barrier support — PIE often resolves on its own if the area isn't repeatedly re-traumatised. A simple barrier-supportive routine (gentle cleanser, ceramide moisturiser, daily SPF) is sometimes enough.

When to see a dermatologist (not a skincare app)

• If a mark is changing shape, growing, or has irregular borders — that's a moles-and-melanoma question, not a PIH/PIE question.
• If you've used a skin-of-colour-appropriate routine consistently for 4+ months and seen no progress.
• If you're considering hydroquinone, prescription retinoids, or laser — these need real medical input.
• If the mark is bothering you enough that the wrong treatment costs you more than a dermatologist visit. (For most adults, that threshold is shorter than they realise.)

How Lumière handles PIH vs PIE

Every scan on Lumière returns PIH and PIE as separate findings, never blended into a single "hyperpigmentation" bullet. The analysis commits to your Fitzpatrick phototype and Monk Skin Tone classification before it interprets any pigmentation finding, which is the structural fix for the training-data bias problem described above. The full methodology — including how vascular signs, melasma, and solar lentigines are differentiated separately — is published openly at lumiere-skin.us/methodology.

Lumière is free on iOS today. If your scan reads PIH and PIE on your skin and gives you back two separate readings calibrated to your specific tone, that is the calibration working as intended. If a scan returns a single undifferentiated "hyperpigmentation" finding on your face, we want to hear about it specifically — that's a bug, not a feature, and we read every report.

FAQ

What's the main difference between PIH and PIE?

PIH is brown / dark and caused by excess melanin. PIE is red / pink / purple and caused by damaged blood vessels. Same triggers (acne, irritation, injury); two completely different residual mechanisms.

How do I tell if I have PIH or PIE?

Press a glass slide gently against the mark. PIE blanches (turns lighter) under pressure because it's blood. PIH does not blanch because it's melanin. Five-second test, very reliable.

Can I have both PIH and PIE at the same time?

Yes — common, especially when multiple acne lesions have healed in the same area. Treatment plans for users with both should target both pathways: vascular-supportive ingredients for PIE plus melanin-targeted ingredients for PIH, with daily SPF as the non-negotiable foundation.

Why do most skincare apps treat them the same?

Most consumer skincare AI is trained on datasets that over-represent Fitzpatrick I–III skin, where PIE is more common. The training distribution biases the model toward reading post-acne marks as a single category. Apps that anchor every analysis to Fitzpatrick I–VI plus Monk Skin Tone classification first are structurally able to make the PIH/PIE distinction.

Can sunscreen really make a difference for PIH on dark skin?

Yes — and it's the most underrated PIH treatment. UV exposure stimulates already-active melanocytes to produce even more pigment in the affected area. Daily broad-spectrum SPF 50+ doesn't fade existing PIH, but it lets every other treatment work without being constantly undone.

The takeaway

PIH and PIE are not the same finding, and treating them as one is the single most common mistake consumer skincare AI makes on darker skin. A blanch test resolves most cases in five seconds; a tone-aware analysis resolves the rest. The treatments diverge meaningfully — and on Fitzpatrick IV–VI skin, the cost of the wrong protocol is months of wasted effort while the marks don't fade.

If you want to read more about how Lumière calibrates the analysis across the full Fitzpatrick range — including the specific clinical frameworks (Monk, ITA, mMASI, GAGS) we anchor to — read the full methodology page.